ADVANCED ENDOMETRIAL CANCER
Clinical trials for ADVANCED ENDOMETRIAL CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED ENDOMETRIAL CANCER trials appear
Sign up with your email to follow new studies for ADVANCED ENDOMETRIAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody takes aim at Hard-to-Treat cancers in first human trial
Disease control Recruiting nowThis early-stage trial is testing a new drug called CTIM-76 in people with advanced ovarian, testicular, or endometrial cancers that have not responded to standard treatments. CTIM-76 is a bispecific antibody designed to attach to a protein called Claudin-6 on cancer cells and he…
Matched conditions: ADVANCED ENDOMETRIAL CANCER
Phase: PHASE1 • Sponsor: Context Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug combo shows promise for tough gynecological cancers
Disease control Recruiting nowThis study tests an experimental drug called SKB518, given alone or with chemotherapy, in 280 people with advanced ovarian, cervical, or endometrial cancers. The goal is to see if the drug can shrink tumors or slow cancer growth. Researchers will also monitor side effects.
Matched conditions: ADVANCED ENDOMETRIAL CANCER
Phase: PHASE2 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New antibody drug targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-stage trial is testing an experimental drug called MOv18 IgE in people with advanced ovarian, endometrial, or triple-negative breast cancers that have a specific protein (folate receptor alpha) on their cells. The study has two parts: first, finding the safest dose, an…
Matched conditions: ADVANCED ENDOMETRIAL CANCER
Phase: PHASE1 • Sponsor: Epsilogen Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New hope for advanced endometrial cancer: immunotherapy combo under study
Disease control Recruiting nowThis study tests two drugs, envafolimab (an immunotherapy) and lenvatinib (a targeted therapy), alone or together, in 108 people with advanced endometrial cancer that has worsened after standard chemotherapy. The main goal is to see if the drugs shrink tumors. Researchers will al…
Matched conditions: ADVANCED ENDOMETRIAL CANCER
Phase: PHASE2 • Sponsor: 3D Medicines (Sichuan) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Immune cell combo shows promise against tough gynecologic cancers
Disease control Recruiting nowThis early-phase study tests a new treatment that combines specially grown immune cells (cCTL) with immunotherapy for people with advanced gynecologic cancers like ovarian, cervical, or endometrial cancer. The goal is to see if the combination is safe and can shrink tumors. About…
Matched conditions: ADVANCED ENDOMETRIAL CANCER
Phase: EARLY_PHASE1 • Sponsor: Obstetrics & Gynecology Hospital of Fudan University • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC